Improved efficacy and safety in Danish patients treated with risperidone long-acting injectable

被引：0
|
作者：
Glue, P
Lublin, H
Refshammer, C
Lex, A
Lang-Jensen, L
机构：
[1] Vestfyn, Sygehus Fyn, Middelfart, Denmark
[2] Rigshosp, Dept Psychiat, Copenhagen, Denmark
[3] Dept Psychiat, Kolding, Denmark
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S402 / S403
页数：2
相关论文
共 50 条
  • [1] French psychotic patients treated with risperidone long-acting injectable: Improved efficacy and safety
    Llorca, P-M.
    Dumont, P.
    Palazzolo, J.
    Raymondet, P.
    Moreau-Mallet, V.
    Bouhours, P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S270 - S270
  • [2] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [3] Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia
    Bouhours, P
    Schreiner, A
    Rendall, MR
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 171
  • [4] Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone
    Schmauss, Max
    Sacchetti, Emilio
    Kahn, Jean-Pierre
    Medori, Rossella
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 85 - 92
  • [5] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [6] Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies
    Möller, HJ
    Llorca, PM
    Sacchetti, E
    Martin, S
    Medori, R
    Parellada, E
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S76 - S76
  • [7] Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies
    Möller, HJ
    Llorca, PM
    Sacchetti, E
    Martin, SD
    Medori, R
    Parellada, E
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : 121 - 130
  • [8] Experience with out-patients treated with long-acting injectable risperidone
    Madera, P. M. Holgado
    Martin, J. Diez
    Vazquez, E. Bermudez
    Mateos, R. Lopez
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S155 - S156
  • [9] Risperidone long-acting injectable improves efficacy and safety in schizophrenic patients after changing from oral risperidone
    Kusters, J
    Glue, P
    Katsafouros, K
    Boon, H
    Medori, R
    Parellada, E
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S79
  • [10] Long-acting injectable risperidone
    Ehret, MJ
    Fuller, MA
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2122 - 2127
12345